![James Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Campbell
Chairman at
PRESCIENT THERAPEUTICS LIMITED
Net worth: 76 793 $ as of 31/05/2026
Profile
James A. Campbell is the founder of Prevatex Pty Ltd., VITALITY Devices Pty Ltd. Dr. Campbell is currently Chairman at Prescient Therapeutics Ltd. since 2025, Chairman at AusBiotech Ltd., Director at Fusion Biosciences Pty Ltd., and Principal at Gemini Biotechnology.
Former roles include Chief Executive Officer at Photonz Corp.
Ltd., Non-Executive Director at TrivarX Ltd. from 2014 to 2016, Non-Executive Director at CBio Ltd. in 2012, Director at Hatchtech Pty Ltd., Director at Pargenex Pty Ltd., Independent Non-Executive Director at Invion Ltd. from 2012 to 2019, Non-Executive Director at Patrys Ltd. in 2025, Secretary, Chief Operating & Financial Officer at ChemGenex Pharmaceuticals Pty Ltd. from 2009 to 2012, Principal at the University of Melbourne, Consultant at Booz Allen Hamilton, Inc., Principal at Commonwealth Scientific & Industrial Research Organisation, and Investment Committee Member at Symbiosis Group Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/06/2025 | 1,368,365 ( 0.13% ) | 76 793 $ | 31/05/2026 |
James Campbell active positions
| Companies | Position | Start |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Chairman | 30/03/2025 |
VITALITY Devices Pty Ltd.
 VITALITY Devices Pty Ltd. Medical DistributorsDistribution Services Wholesales medical devices | Founder | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Chairman | - |
Fusion Biosciences Pty Ltd. | Director/Board Member | - |
Gemini Biotechnology | Corporate Officer/Principal | - |
Former positions of James Campbell
| Companies | Position | End |
|---|---|---|
| PATRYS LIMITED | Chief Executive Officer | 01/07/2025 |
| INVION LIMITED | Director/Board Member | 21/12/2019 |
| TRIVARX LIMITED | Director/Board Member | 30/09/2016 |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology Develops new generation products for the treatment of autoimmune and inflammatory diseases | Director/Board Member | 05/09/2012 |
| ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░ | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
45
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Prescient Therapeutics Ltd.
 Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Booz Allen Hamilton, Inc.
 Booz Allen Hamilton, Inc. Packaged SoftwareTechnology Services Builds advanced technology to fast-track results for government—boosting efficiencies, saving money and safeguarding | Technology Services |
TrivarX Ltd.
 TrivarX Ltd. Packaged SoftwareTechnology Services Engages in the clinical research, product development and early stage commercialization of a mental health technology | Technology Services |
Commonwealth Scientific & Industrial Research Organisation
 Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Provides scientific and industrial research services | Commercial Services |
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology Develops new generation products for the treatment of autoimmune and inflammatory diseases | Health Technology |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical product company | Health Technology |
Symbiosis Group Ltd.
 Symbiosis Group Ltd. Investment ManagersFinance Symbiosis Group invests in private companies located in Australia. The firm focuses on life sciences companies. The firm provides financing for early stage transactions. | Finance |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Pargenex Pty Ltd. | |
Invion Ltd.
 Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Gemini Biotechnology | |
VITALITY Devices Pty Ltd.
VITALITY Devices Pty Ltd. Medical DistributorsDistribution Services Wholesales medical devices | Distribution Services |
Fusion Biosciences Pty Ltd. | |
Prevatex Pty Ltd.
 Prevatex Pty Ltd. BiotechnologyHealth Technology Engages in research and development of probiotic-based biotherapeutics | Health Technology |
- Stock Market
- Insiders
- James Campbell
